Pharmacokinetics of norfloxacin and its N-desethyl- and oxo-metabolites in broiler chickens.
Norfloxacin was given to 2 groups of chickens (8 chickens/group) at a dosage of 8 mg/kg of body weight, IV and orally. For 24 hours, plasma concentration was monitored serially after each administration. Another group of chickens (n = 30) was given 8 mg of norfloxacin/kg orally every 24 hours for 4 days, and plasma and tissue concentrations of norfloxacin and its major metabolites desethylenenorfloxacin and oxonorfloxacin were determined serially after the last administration of the drug. Plasma and tissue concentrations of norfloxacin, desethylenenorfloxacin, and oxonorfloxacin were measured by use of high-performance liquid chromatography. Pharmacokinetic variables were calculated, using a 2-compartment open model. For norfloxacin, the elimination half-life (t1/2 beta) and the mean +/- SEM residence time for plasma were 12.8 +/- 0.59 and 15.05 +/- 0.81 hours, respectively, after oral administration and 8.0 +/- 0.3 and 8.71 +/- 0.23 hours, respectively, after IV administration. After single oral administration, norfloxacin was absorbed rapidly, with Tmax of 0.22 +/- 0.02 hour. Maximal plasma concentration was 2.89 +/- 0.20 microgram/ml. Oral bioavailability of norfloxacin was found to be 57.0 +/- 2.4%. In chickens, norfloxacin was mainly converted to desethylenenorfloxacin and oxonorfloxacin. Norfloxacin parent drug and its 2 major metabolites were widely distributed in tissues. Considerable tissue concentrations of norfloxacin, desethylenenorfloxacin, and oxonorfloxacin were found when norfloxacin was administered orally (8 mg/kg on 4 successive days). The concentration of the parent fluoroquinolone in fat, kidneys, and liver was 0.05 micrograms/g on day 12 after the end of dosing.
Anadón
A
A
CSIC, Department of Pharmacology, Faculty of Medicine, Universidad Cumplutense, Madrid, Spain.
Martinez-Larrañaga
M R
MR
Velez
C
C
Díaz
M J
MJ
Bringas
P
P
D000818:Animals; D002645:Chickens / Q000378:metabolism*; D008297:Male; D009643:Norfloxacin / Q000031:analogs & derivatives / Q000097:blood / Q000493:pharmacokinetics*; D014018:Tissue Distribution
C037271:oxonorfloxacin; C048434:3-carboxy-4-oxo-6-fluoro-7-(1-piperazinyl)-1,4-dihydroquinolone; D009643:Norfloxacin